- Opportunistic chronic disease detection on CT
- Targets radiology needs rather than a generic suite
- Scales to organization-wide healthcare rollouts
Nanox.AI
Chronic disease detection on routine CT
SF7.6
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Support reporting language consistency
Support reporting language consistency
Best for
Health systems and population health programs
Pricing
Custom
SoftFinders Score
7.6 / 10
Overview
What is Nanox.AI?
Nanox.AI is an AI imaging division, formerly Zebra Medical Vision, that analyzes routine CT scans for chronic disease indicators. The product is positioned around imaging triage, finding prioritization, and radiologist productivity rather than autonomous interpretation, and regulatory clearance scope and validation depth vary by clinical indication. Buyers should confirm clearance details, integration with PACS and worklist tools, and impact metrics for the specific reading workflow being supported.
Buyers usually compare Nanox.AI for opportunistic chronic disease detection on CT, with health systems and population health programs as the core audience. The trade-off to keep in mind: clearance scope varies by indication. Pricing is sales-led and scoped per buyer rather than posted publicly. A focused pilot, scoped to one workflow, is usually the cleanest way to test fit.
KEY FEATURES
What you get out of the box
Finding Triage
Flags suspected critical findings for prioritization
Worklist Integration
Integrates flagged studies into radiologist worklist
Multi Modality
Supports CT, MRI, X-ray, and related modalities
Care Coordination
Routes alerts to relevant care team members
Reporting Support
Drafts or supports impressions and report language
Imaging Workflow
Connects across PACS and reading environments
USE CASES
Where teams put it to work
Support reporting language consistency
Triage screening exams at scale
Reduce missed findings on busy lists
Bridge imaging and downstream pathways
Track outcomes from flagged studies
Standardize follow-up recommendations
Editorial Take
What we like, and what to verify
- Clearance scope varies by indication
- Radiologist confirmation required on every study
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Gleamer SF 8
Why consider it
Broad X-ray AI suite for radiology
Qure.ai SF 8.1
Why consider it
Global chest, CT, and stroke imaging AI
RapidAI SF 8
Why consider it
Stroke and vascular imaging triage platform
Subtle Medical SF 7.7
Why consider it
AI image enhancement for MRI and PET
Imagen Technologies SF 7.5
Why consider it
AI-supported radiology reads and workflow
Riverain Technologies SF 7.4
Why consider it
Chest and lung X-ray detection AI
FAQ